FDA Approved: SUBVENITE — Original Application (OWP Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved SUBVENITE (lamotrigine) through an Original Application filed by OWP Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy

Drugs mentioned

• SUBVENITE (LAMOTRIGINE)

Snippet

ORIG AP for SUBVENITE (LAMOTRIGINE)